[
  {
    "ts": null,
    "headline": "Charles River Laboratories (CRL): Buy, Sell, or Hold Post Q3 Earnings?",
    "summary": "Charles River Laboratories has had an impressive run over the past six months as its shares have beaten the S&P 500 by 20.5%. The stock now trades at $189.18, marking a 27% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
    "url": "https://finnhub.io/api/news?id=4149e31a2ee5231e765a73b98f5ed3e1541ae2b98de5c3667950ce06bd919071",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770609701,
      "headline": "Charles River Laboratories (CRL): Buy, Sell, or Hold Post Q3 Earnings?",
      "id": 138616280,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Charles River Laboratories has had an impressive run over the past six months as its shares have beaten the S&P 500 by 20.5%. The stock now trades at $189.18, marking a 27% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
      "url": "https://finnhub.io/api/news?id=4149e31a2ee5231e765a73b98f5ed3e1541ae2b98de5c3667950ce06bd919071"
    }
  }
]